Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

NCT05220293 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Single site study OT-007 re-opened as multi-site OT-007B study

Conditions

Chronic Rhinosinusitis (Diagnosis)

Interventions

DRUG: Betamethasone Dipropionate Nasal Cream 0.0644%
DEVICE: Pre-filled syringe and applicator device

Sponsor

Oticara Australia PTY LTD